- ►diabetesjournals.org NP Murphy, SM Keane, KK Ong, M Ford-Adams … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—Compared with R/NPH therapy, LIS/GLAR was associated with lower mean
blood glucose levels (LIS/GLAR versus R/NPH): fasting (8.0 vs. 9.2 mmol/l, P <
0.0001), 2 h postbreakfast (8.1 vs. 10.7 mmol/l, P < 0.0005), prelunch (8.9 ... Cited by 118 - Related articles - BL Direct - All 6 versions
HP Chase, B Dixon, J Pearson, R Fiallo- … - The Journal of pediatrics, 2003 - Elsevier Data from 114 subjects, age 2 to 18 years (mean, 12.2 years; 54 boys, 60 girls),
were collected for 9 months before and 9 months after IG treatment. During IG
therapy, all subjects received morning neutral protamine Hagedorn insulin ... Cited by 94 - Related articles - All 12 versions
EH Hathout, L Fujishige, J Geach, M … - Diabetes Technology & Therapeutics, 2003 - liebertonline.com To determine the effect of insulin glargine on glycemic control in pediatric
type 1 and 2 di- abetes, a retrospective repeated-measure analysis of variance
was performed of hemoglobin A1C (HbA1C), frequency of hypoglycemia and ... Cited by 47 - Related articles - BL Direct - All 3 versions
[CITATION] Pediatric Study Group of Insulin Glargine. Comparative trial between insulin glargine and …
- Free from Publisher P Rossetti, S Pampanelli, C Fanelli, F … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—Mean daily blood glucose was lower with dinnertime glargine (7.5 ±
0.2 mmol/l) or bedtime glargine (7.4 ± 0.2 mmol/l) versus NPH (8.3 ± 0.2
mmol/l) (P < 0.05). A greater percentage of blood glucose values were at ... Cited by 121 - Related articles - BL Direct - All 5 versions
LC Deeb, JH Holcombe, R Brunelle, S Zalani, … - Pediatrics, 2001 - pediatrics.org.p.angrylapdog.com Research Design and Methods. A 3-way crossover, open-label study involving 61
prepubertal children (ages 2.9-11.4 years) with type 1 diabetes. The children
were randomly assigned to receive regular human insulin 30 to 45 minutes ... Cited by 57 - Related articles - BL Direct - All 7 versions
E Schober, E Schoenle, J Van Dyk, K … - Journal of pediatric endocrinology & metabolism: JPEM, 2002 - ncbi.nlm.nih.gov The objective of this study was to compare the efficacy and safety of insulin
glargine, a long-acting insulin analog, with NPH insulin in children and
adolescents with type 1 diabetes mellitus (T1DM). In a multicenter, ... Cited by 53 - Related articles - BL Direct - All 3 versions
JAH Ahern, EA Boland, R Doane, JJ Ahern, P … - Pediatric Diabetes, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 127 - Related articles - BL Direct - All 3 versions
- Free from Publisher P Raskin, L Klaff, R Bergenstal, JP Halle, D … - Diabetes Care, 2000 - Am Diabetes Assoc C urrently available intermediately or long-acting insulin products used for
basal insulin treatment are associated with either pronounced insulin peaks
after injection, a duration of action that is too short to maintain ... Cited by 201 - Related articles - BL Direct - All 7 versions
